Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial.

Background: In areas of endemic transmission, malaria in pregnancy is associated with severe maternal anaemia and low-birthweight babies. We studied the efficacy of intermittent treatment doses of sulphadoxine-pyrimethamine in preventing malaria and severe anaemia in pregnancy in a double-blind plac...

Full description

Bibliographic Details
Published in:Lancet Vol. 353; no. 9153; pp. 632 - 637
Main Authors: Shulman, C.E., Dorman, E.K., Cutts, F., Kawuondo, K., Bulmer, J.N., Peshu, N., Marsh, K.
Format: clinical trial research randomized controlled trial Journal Article
Published: Lancet 2/20/1999
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=1569082&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 1569082
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01406736
        LAN
      jtl: Lancet
      issn: 01406736
      maglogo: N
    pubinfo:
      dt: 2/20/1999
      vid: 353
      iid: 9153
      pid: 1297
      pub: Lancet
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        1569082
        1569082
        NLM10030329
        1569082
        10.1016/S0140-6736(98)07318-8
        NLM10030329
        1569082
      ppf: 632
      ppct: 5
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial.
      aug:
        au:
          Shulman, C.E.
          Dorman, E.K.
          Cutts, F.
          Kawuondo, K.
          Bulmer, J.N.
          Peshu, N.
          Marsh, K.
      sug:
        subj:
          Sulfadoxine Therapeutic Use
          Pregnancy Complications, Parasitic Prevention and Control
          Anemia Prevention and Control
          Pyrimethamine Therapeutic Use
          Antimalarials Therapeutic Use
          Malaria Prevention and Control
          Malaria Complications
          Placebos
          Sulfadoxine Administration and Dosage
          Parasitemia Prevention and Control
          Pregnancy
          Drug Combinations
          Double-Blind Studies
          Kenya
          Drug Administration Schedule
          Parity
          Public Health
          Human
          Insecticides
          Anemia Etiology
          Pyrimethamine Administration and Dosage
          Antimalarials Administration and Dosage
          Treatment Outcomes
          Bedding and Linens
          Hemoglobins Analysis
          Female
          Clinical Trials
          Validation Studies
          Comparative Studies
          Evaluation Research
          Multicenter Studies
          Randomized Controlled Trials
          Questionnaires
          Female
      ab: Background: In areas of endemic transmission, malaria in pregnancy is associated with severe maternal anaemia and low-birthweight babies. We studied the efficacy of intermittent treatment doses of sulphadoxine-pyrimethamine in preventing malaria and severe anaemia in pregnancy in a double-blind placebo-controlled trial among primigravid women living in Kilifi District, Kenya.Methods: Between January, 1996, and April, 1997, 1264 primigravid women were recruited when they attended for antenatal care, and randomly assigned sulphadoxine-pyrimethamine (640) or placebo (624). Women received one, two, or three doses of study medication depending on the duration of gestation at enrolment. Primary outcome measures were severe anaemia (haemoglobin <8 g/dL) and malaria parasitaemia, assessed at 34 weeks of gestation. Analyses were based on intention to treat among women who had study blood tests at 34 weeks.Findings: 30 (5.3%) of 567 women in the sulphadoxine-pyrimethamine group and 199 (35.3%) of 564 in the placebo group had peripheral parasitaemia (protective efficacy 85% [95% CI 78-90], p<0.0001). 82 (14.5%) and 134 (23.7%) had severe anaemia (protective efficacy 39% [22-52], p<0.0001). Even women who booked late and received only one dose of sulphadoxine-pyrimethamine benefited significantly from the intervention. The effects were seen both in women who owned insecticide-treated bednets and in women who did not.Interpretation: Intermittent presumptive treatment with sulphadoxine-pyrimethamine is an effective, practicable strategy to decrease the risk of severe anaemia in primigravidae living in malarious areas.
      pubtype: Academic Journal
      doctype:
        clinical trial
        research
        randomized controlled trial
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N